EGFR and squamous cell carcinoma: By histological analysis, the majority of tumors were adencarcinoma (52/78, 66.7%) or squamous carcinoma (19/78, 24.4%), moderately differentiated (33/63, 52.4%), and positive for EGFR mutation (19/30, 63.3%).